Venlafaxine Hydrochloride
- Product NDC
- 53002-2366
- 11-digit product format
- 530022366
- Labeler code
- 53002
- Product ID
- 53002-2366_0c851fea-3353-4832-b5a1-931a502ccce2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Venlafaxine Hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA200834
- Marketing category
- ANDA
- Marketing start
- 2011-06-01
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 38 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-2366-3 | Venlafaxine Hydrochloride | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | | 1 |
| 53002-2366-9 | Venlafaxine Hydrochloride | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-2366 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [RPK PHARMACEUTICALS, INC.] | 1 | Legacy NDC, 2 package rows | 20220331_4d02b6ce-8a0c-411b-853f-ef78f4bbef7d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-2366-3 | 53002236603 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (53002-2366-3) | 2021-01-01 | 0000-00-00 | No | No | Current |
| 53002-2366-9 | 53002236609 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (53002-2366-9) | 2021-01-01 | 0000-00-00 | No | No | Current |